Skip to main content

Pfenex shares rise on collaboration deal with Hospira

Partners are developing a generic version of Genentech’s Lucentis eye treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.